Involvement of phospholipase A2 in axonal regeneration of brain noradrenergic neurones

Neuroreport. 1993 Apr;4(4):371-4. doi: 10.1097/00001756-199304000-00007.

Abstract

We have previously reported that antidepressants such as desipramine (DMI) induce axonal regeneration of brain noradrenergic neurons. In the present experiments, the role of phospholipase A2 (PLA2) in the regeneration of brain noradrenergic axons was studied. Symmetrical sites of the rat frontal cortex were pretreated with 6-hydroxy-dopamine (6-OHDA). Then, the same cortical site of one hemisphere was infused with DMI, while the corresponding site of the other hemisphere was infused with DMI plus 4-bromphenacyl bromide (BPB), a PLA2 inhibitor. The DMI-induced axonal regeneration was attenuated by BPB, while the PLA2 activator melittin induced the regeneration of noradrenergic axons. These findings suggest that activation of PLA2 is involved in the regeneration of brain noradrenergic axons.

MeSH terms

  • Acetophenones / pharmacology
  • Animals
  • Axons / drug effects
  • Axons / enzymology*
  • Desipramine / pharmacology
  • Female
  • Frontal Lobe / drug effects
  • Frontal Lobe / physiology*
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology*
  • Neurons / drug effects
  • Neurons / physiology*
  • Norepinephrine / physiology*
  • Oxidopamine / pharmacology
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A / drug effects
  • Phospholipases A / physiology*
  • Phospholipases A2
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Acetophenones
  • Oxidopamine
  • Phospholipases A
  • Phospholipases A2
  • 4-bromophenacyl bromide
  • Desipramine
  • Norepinephrine